A Rosen, A van Kuilenburg… - Case Reports in …, 2011 - content.karger.com We present the case of a 19-year-old female with nasopharyngeal carcinoma, who received two courses of chemotherapy with 5-fluorouracil (5-FU) in combination with folic acid and cisplatin. Upon developing esophageal strictures in the course of her radiotherapy, she ...
[HTML] from oxfordjournals.orgFA Sinicrope, NR Foster… - Journal of the …, 2011 - jnci.oxfordjournals.org Methods We included stage II and III colon carcinoma patients (n = 2141) who were treated in randomized trials of 5-FU-based adjuvant therapy. Tumors were analyzed for microsatellite instability by polymerase chain reaction and/or for MMR protein expression by ... Cited by 1 - Related articles - All 5 versions
[HTML] from plos.orgL Stevenson, WL Allen, I Proutski, G Stewart… - PloS one, 2011 - dx.plos.org The role of the calcium binding protein, Calbindin 2 (CALB2), in regulating the response of colorectal cancer (CRC) cells to 5-Fluorouracil (5-FU) was investigated. Real-time RT-PCR and Western blot analysis revealed that CALB2 mRNA and protein expression were down-regulated in ... Related articles - Cached - All 3 versions
[HTML] from biomedcentral.comC Papadimitriou, P Papakostas, M Karina… - BMC …, 2011 - biomedcentral.com Colon cancer is a public health problem worldwide. Adjuvant chemotherapy after surgical resection for stage III colon cancer has been shown to improve both progression-free and overall survival, and is currently recommended as standard therapy. However, its value for ... Related articles - Cached - All 7 versions
AM Huehls, JM Wagner, CJ Huntoon, L Geng… - Cancer Research, 2011 - AACR ... cells 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer Poly(ADP-ribose) polymerase inhibition synergizes with ... Page 2. Poly(ADP-ribose) polymerase inhibition synergizes with 5-fluorodeoxyuridine but not 5-fluorouracil in ovarian cancer cells ... Related articles - All 2 versions